Eventum Orthopaedics, a UK medtech company whose device could revolutionise knee replacement surgery has raised a further £3.8m from NPIF II - Mercia Equity Finance, which is managed by Mercia Ventures as part of the Northern Powerhouse Investment Fund II (NPIF II), Mercia’s EIS funds and private investors including leading surgeons.

Eventum's QuadSense device helps surgeons to precisely cut and place the kneecap in total knee replacements. Currently over 2 million patients a year have knee replacements globally, yet around 20% are not fully satisfied with the outcome. Eventum believes the key to improving success rates is the position of the kneecap, which plays a crucial role in the knee's function.